Emm

Emm is a health intelligence company and pioneer in biowearable innovation, dedicated to closing the gender health data gap.

The company developed the Emm Cup, the world’s first regulatory-approved smart menstrual cup, establishing a critical reproductive health data layer of objective, continuous baseline metrics that do not currently exist at scale. By utilizing integrated biosensors and a secure digital platform, the medical-grade biowearable automatically measures precise flow volume and biological patterns, syncing data only when docked in its charging case.

Backed by a historic $9M (£6.8M) oversubscribed funding round led by Lunar Ventures, Labcorp Venture Fund, and specialized healthtech angels, Emm is establishing the definitive phenotypic dataset for menstruation. Our technology marks the beginning of a lifetime health partnership from puberty through menopause, fundamentally changing the future of personalized reproductive care, screening, and diagnostic support.

Website: emm.co

Headquarters: Bristol & London, UK

Data Privacy: Built on medical-grade data encryption